# Idorsia Pharmaceuticals UK (Idorsia Pharmaceuticals UK Limited)

Private limited company registered in London, classed under “Wholesale of pharmaceutical goods”.

- Company number: 13515638
- Status: Active
- Type: Private limited company
- Incorporated: 16 July 2021
- Registered office: 20 Eastbourne Terrace, London, W2 6LG
- Location: London
- Activity: Wholesale of pharmaceutical goods

## Latest filed profit

Profit after tax in the year to 31 December 2025: **£5.73k**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Idorsia Pharmaceuticals UK do?

Private limited company registered in London, classed under “Wholesale of pharmaceutical goods”.

### How much turnover does Idorsia Pharmaceuticals UK make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/idorsia-pharmaceuticals-uk-13515638

### Is Idorsia Pharmaceuticals UK profitable?

Yes: it made a profit after tax of £5.73k in the year to 31 December 2025, its latest filed accounts.

### How many people work at Idorsia Pharmaceuticals UK?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/idorsia-pharmaceuticals-uk-13515638

### Who runs and owns Idorsia Pharmaceuticals UK?

Its directors are Isabelle Marie Therese Mamet, Robert Justin Moore, Alistair Paice, Kerry Janet Prest. Its owners are shown to subscribers.

### Where is Idorsia Pharmaceuticals UK based?

Its registered office is 20 Eastbourne Terrace, London, W2 6LG, in London.

### When was Idorsia Pharmaceuticals UK founded?

Idorsia Pharmaceuticals UK Limited was incorporated on 16 July 2021.

### Is Idorsia Pharmaceuticals UK still trading?

The register lists Idorsia Pharmaceuticals UK Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-09-18: Full accounts made up to 31 December 2025
- 2026-07-24: Director's details changed for Robert Justin Moore on 24 July 2026
- 2026-07-22: Replacement Filing for the appointment of Mrs Isabelle Mamet as a director
- 2025-10-07: Appointment of Mrs Kerry Janet Prest as a director on 11 September 2025
- 2025-09-24: Accounts for a small company made up to 31 December 2024
- 2024-09-26: Accounts for a small company made up to 31 December 2023
- 2024-05-23: Termination of appointment of Peter Graham as a director on 10 May 2024
- 2023-10-25: Accounts for a small company made up to 31 December 2022
- 2023-06-22: Appointment of Isabelle Mamet as a director on 21 June 2023
- 2023-06-21: Appointment of Peter Graham as a director on 21 June 2023
- 2023-06-21: Appointment of Alistair Paice as a director on 21 June 2023
- 2022-07-07: Current accounting period extended from 31 December 2021 to 31 December 2022
- 2022-06-01: Statement of capital following an allotment of shares on 1 June 2022 · GBP 26,000
- 2021-11-12: Current accounting period shortened from 31 July 2022 to 31 December 2021
- 2021-11-12: Registered office address changed from 33 st James's Square London SW1Y 4JS to 20 Eastbourne Terrace London W2 6LG on 12 November 2021
- 2021-09-21: Termination of appointment of Arno Groenewoud as a director on 13 September 2021
- 2021-09-21: Appointment of Robert Justin Moore as a director on 13 September 2021
- 2021-07-16: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/idorsia-pharmaceuticals-uk-13515638